Boardroom Alpha
Start trial
Boardroom Alpha
CL · Additional Proxy Materials (DEFA14A) · Filed March 25, 2026

Colgate Palmolive Co — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 25, 2026
Ticker
CL
Accession
0001308179-26-000137
Colgate Palmolive Co on Boardroom AlphaView on SEC EDGAR
Boardroom Alpha · Filing insights

Colgate-Palmolive urges voting For its director slate and routine items; opposes DEI removal and independent chair proposals.

About Colgate Palmolive Co
Market cap
$70.6B
1Y TSR
+0.9%
3Y TSR
+7.7%
Board grade
C+
Sector
Consumer Defensive
CEO
Noel R Wallace
Last annual meeting: May 8, 2026 · View full Colgate Palmolive Co profile →
Colgate Palmolive - DEFA14A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )

☑ Filed by the Registrant ☐ Filed by a party other than the Registrant      

CHECK THE APPROPRIATE BOX:
☐   Preliminary Proxy Statement
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
☑   Definitive Additional Materials
☐ Soliciting Material under §240.14a-12

 

Colgate-Palmolive Company

(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
☑   No fee required
☐ Fee paid previously with preliminary materials
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     
                                                                                            

 

300 PARK AVENUE
NEW YORK, NY 10022-7499


 

Your Vote Counts!

COLGATE-PALMOLIVE COMPANY

2026 Annual Meeting to be held on May 8, 2026
Deadline to vote prior to the Annual Meeting is
May 7, 2026 11:59 PM ET
 
 
 
 
 
 
 

 
 
 
 
 
 
V85263-Z91955-Z91954               
                                  
                                           

You hold shares in COLGATE-PALMOLIVE COMPANY and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on May 8, 2026.

Get informed before you vote
View the Notice of 2026 Annual Meeting of Stockholders and Proxy Statement and 2025 Annual Report online at www.ProxyVote.com OR you can receive a free paper or email copy of the material(s) by requesting prior to April 24, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

  For complete information and to vote, visit www.ProxyVote.com
     
Control #  
       

 

 

Smartphone users

 

Point your camera here and
vote without entering a
control number

    

Vote During the Virtual Meeting*

May 8, 2026

10:00 a.m. Eastern Daylight Time

      Virtually at:
www.virtualshareholdermeeting.com/CL2026

 

 

 

*Please check the meeting materials for any special requirements for meeting attendance.

 

Vote at www.ProxyVote.com

 

 

 

THIS IS NOT A VOTABLE BALLOT

 

This is an overview of the proposals being presented at the
upcoming stockholder meeting. Please follow the instructions on
the reverse side to vote these important matters.

 

 

 

 

     
Voting Items

Board
Recommends

1. Election of directors  
  Nominees:  
1a. John P. Bilbrey  For
1b. Christopher S. Boerner  For
1c. John T. Cahill  For
1d. Lisa M. Edwards  For
1e. C. Martin Harris  For
1f. Martina Hund-Mejean  For
1g. Kimberly A. Nelson  For
1h. Brian O. Newman  For
1i. Lorrie M. Norrington  For
1j. Noel Wallace  For
2. Ratify selection of PricewaterhouseCoopers LLP as Colgate’s independent registered public accounting firm.  For
3. Advisory vote on executive compensation.  For
4. Stockholder proposal entitled “Remove DEI from Board Candidate Considerations.”  Against
5. Stockholder proposal entitled “Independent Board Chairman.”  Against
   

 

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.

 

V85264-Z91955-Z91954

 

     
                                                                                            

 

300 PARK AVENUE
NEW YORK, NY 10022-7499


 

Your Vote Counts!

COLGATE-PALMOLIVE COMPANY

2026 Annual Meeting to be held on May 8, 2026
For shares held in a Plan,
vote by May 6, 2026 11:59 PM ET
 
 
 
 
 
 
 

 
 
 
 
 
 
V85265-P45887-Z92033               
                                  
                                           

 

You have a plan interest in shares in COLGATE-PALMOLIVE COMPANY and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on May 8, 2026.

Get informed before you vote
View the Notice of 2026 Annual Meeting of Stockholders and Proxy Statement and 2025 Annual Report online at www.ProxyVote.com OR you can receive a free paper or email copy of the material(s) by requesting prior to April 24, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

  For complete information and to vote, visit www.ProxyVote.com
     
Control #  
       

 

 

Smartphone users

 

Point your camera here and
vote without entering a
control number

  

Attend the Virtual Meeting*

May 8, 2026

10:00 a.m. Eastern Daylight Time

      Virtually at:
www.virtualshareholdermeeting.com/CL2026

 

 

 

*Please check the meeting materials for any special requirements for meeting attendance.

 

Vote at www.ProxyVote.com

 

 

 

THIS IS NOT A VOTABLE BALLOT

 

This is an overview of the proposals being presented at the
upcoming stockholder meeting. Please follow the instructions on
the reverse side to vote these important matters.

 

 

 

 

     
Voting Items

Board
Recommends

1. Election of directors  
  Nominees:  
1a. John P. Bilbrey  For
1b. Christopher S. Boerner  For
1c. John T. Cahill  For
1d. Lisa M. Edwards  For
1e. C. Martin Harris  For
1f. Martina Hund-Mejean  For
1g. Kimberly A. Nelson  For
1h. Brian O. Newman  For
1i. Lorrie M. Norrington  For
1j. Noel Wallace  For
2. Ratify selection of PricewaterhouseCoopers LLP as Colgate’s independent registered public accounting firm.  For
3. Advisory vote on executive compensation.  For
4. Stockholder proposal entitled “Remove DEI from Board Candidate Considerations.”  Against
5. Stockholder proposal entitled “Independent Board Chairman.”  Against
   

 

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.

 

V85266-P45887-Z92033

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

See Meeting ForecastSchedule a Demo

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Colgate Palmolive Co (CL)

Continue researching
Reference

Frequently asked questions

When did Colgate Palmolive Co file this DEFA14A?
Colgate Palmolive Co (CL) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 25, 2026. The accession number assigned by EDGAR is 0001308179-26-000137.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Colgate-Palmolive urges voting For its director slate and routine items; opposes DEI removal and independent chair proposals. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Colgate Palmolive Co's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Colgate Palmolive Co has filed under CIK 21665, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer